![A. Davis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
A. Davis
Director/Board Member at
GRACE THERAPEUTICS, INC.
Net worth: - $ as of 2026-05-30
Profile
A. Brian Davis currently works at Grace Therapeutics, Inc., as Director from 2023, Cortendo AB, as Chief Financial Officer & IR Contact from 2015, and Xylocor Therapeutics, Inc., as Chief Financial Officer from 2021.
Mr. Davis also formerly worked at MICRO Healthsystems, Inc., as Controller from 1991 to 1994, Neose Technologies, Inc., as Chief Financial Officer & Senior Vice President from 1994 to 2010, Tengion, Inc., as CFO, Secretary & Senior Vice President-Finance in 2014, Strongbridge Biopharma Plc, as Chief Financial & Accounting Officer from 2015 to 2019, and Verrica Pharmaceuticals, Inc., as Chief Financial & Accounting Officer from 2019 to 2021.
Mr. Davis received his undergraduate degree from The College of New Jersey and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-01-07 | 0 ( -.--% ) | - $ | 2026-05-30 |
A. Davis active positions
| Companies | Position | Start |
|---|---|---|
| GRACE THERAPEUTICS, INC. | Director/Board Member | 2023-10-09 |
Cortendo AB
 Cortendo AB Miscellaneous Commercial ServicesCommercial Services Pioneered cortisol inhibition as a treatment for Metabolic Syndrome | Director of Finance/CFO | 2015-03-22 |
Xylocor Therapeutics, Inc.
 Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel gene therapy for cardiovascular disease | Director of Finance/CFO | 2020-12-31 |
Former positions of A. Davis
| Companies | Position | End |
|---|---|---|
| VERRICA PHARMACEUTICALS INC. | Director of Finance/CFO | 2021-07-15 |
| STRONGBRIDGE BIOPHARMA | Director of Finance/CFO | 2019-09-02 |
| TENGION, INC. | Director of Finance/CFO | 2014-12-30 |
Neose Technologies, Inc.
 Neose Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic protein drugs | Director of Finance/CFO | 2010-07-07 |
MICRO Healthsystems, Inc.
 MICRO Healthsystems, Inc. Packaged SoftwareTechnology Services Operating systems computer software | Comptroller/Controller/Auditor | 1993-12-31 |
Training of A. Davis
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
60
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
MICRO Healthsystems, Inc.
MICRO Healthsystems, Inc. Packaged SoftwareTechnology Services Operating systems computer software | Technology Services |
Neose Technologies, Inc.
Neose Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic protein drugs | Health Technology |
Tengion, Inc.
 Tengion, Inc. BiotechnologyHealth Technology Develops new human organs and tissues | Health Technology |
Grace Therapeutics, Inc.
 Grace Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for rare and orphan diseases | Health Technology |
Cortendo AB
Cortendo AB Miscellaneous Commercial ServicesCommercial Services Pioneered cortisol inhibition as a treatment for Metabolic Syndrome | Commercial Services |
The College of New Jersey
 The College of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Strongbridge Biopharma Plc
 Strongbridge Biopharma Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for rare diseases | Health Technology |
Verrica Pharmaceuticals, Inc.
 Verrica Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel gene therapy for cardiovascular disease | Health Technology |
- Stock Market
- Insiders
- A. Davis
